journal cover

Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study

Epilepsy Research

Jun 9, 2014

Vicente VillanuevaA Molins

Abstract

Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) licensed as adjunctive therapy in adults with partial-onset or focal seizures. To evaluate in a clinical practice setting the long-term efficacy and safety of ESL in patients with focal seizures. ESLIBASE was a retrospectiv...read more

Mentioned in this Paper

Topiramate
Licarbazepine
Meta-Analysis (Publications)
Ataxia as Late Effect of Cerebrovascular Disease
Hyponatremia
Epilepsy
Carbamazepine
Measurement of Levetiracetam
Adverse Effects
Eslicarbazepine
5
31
Paper Details
References
  • References21
  • Citations22
123
  • References21
  • Citations22
123

Similar Papers Found In These Feeds

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Selective Ion Transport in Channels & Pumps

Ion channels and pumps are central to a number of cell functions, including membrane excitability and synaptic transmission. With sophisticated imaging, these channels and pumps have been characterized as selective for the ions, sodium, potassium chloride and calcium. Here is the latest research on selection ion transport in channels and pumps.

Epilepsy

Epilepsy is a chronic neurological disorder characterized by unprovoked and recurrent seizures. Discover the latest research on factors and mechanisms that underlie epilepsy here.

Neonatal Seizures

Neonatal seizures are the most common neurological emergency in the neonatal period and are associated with a poor long-term outcome. Discover the latest research on neonatal seizures here.

© 2020 Meta ULC. All rights reserved

Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study

Epilepsy Research

Jun 9, 2014

Vicente VillanuevaA Molins

PMID: 24908564

DOI: 10.1016/j.eplepsyres.2014.04.014

Abstract

Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) licensed as adjunctive therapy in adults with partial-onset or focal seizures. To evaluate in a clinical practice setting the long-term efficacy and safety of ESL in patients with focal seizures. ESLIBASE was a retrospectiv...read more

Mentioned in this Paper

Topiramate
Licarbazepine
Meta-Analysis (Publications)
Ataxia as Late Effect of Cerebrovascular Disease
Hyponatremia
Epilepsy
Carbamazepine
Measurement of Levetiracetam
Adverse Effects
Eslicarbazepine
5
31

Related Papers

Paper Details
References
  • References21
  • Citations22
123
  • References21
  • Citations22
123
/papers/long-term-safety-and-efficacy-of-eslicarbazepine/24908564